Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Return on Capital Employed (2021 - 2025)

Rani Therapeutics Holdings (RANI) has 5 years of Return on Capital Employed data on record, last reported at 7.95% in Q3 2025.

  • For Q3 2025, Return on Capital Employed rose 1016.0% year-over-year to 7.95%; the TTM value through Sep 2025 reached 7.95%, up 1016.0%, while the annual FY2024 figure was 1.95%, 107.0% down from the prior year.
  • Return on Capital Employed reached 7.95% in Q3 2025 per RANI's latest filing, down from 441.92% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 441.92% in Q2 2025 and bottomed at 5.0% in Q1 2025.
  • Average Return on Capital Employed over 5 years is 25.28%, with a median of 0.68% recorded in 2023.
  • The widest YoY moves for Return on Capital Employed: up 44372bps in 2025, down -350bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.4% in 2021, then crashed by -52bps to 0.61% in 2022, then tumbled by -92bps to 1.18% in 2023, then tumbled by -124bps to 2.64% in 2024, then skyrocketed by 401bps to 7.95% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 7.95% in Q3 2025, 441.92% in Q2 2025, and 5.0% in Q1 2025.